Advances in Clinical and Experimental Medicine

Title abbreviation: Adv Clin Exp Med
JCR Impact Factor (IF) – 1.736
5-Year Impact Factor – 2.135
Index Copernicus  – 168.52
MEiN – 70 pts

ISSN 1899–5276 (print)
ISSN 2451-2680 (online)
Periodicity – monthly

Download original text (EN)

Advances in Clinical and Experimental Medicine

2018, vol. 27, nr 5, May, p. 615–621

doi: 10.17219/acem/68693

Publication type: original article

Language: English

Download citation:

  • BIBTEX (JabRef, Mendeley)
  • RIS (Papers, Reference Manager, RefWorks, Zotero)

The effect of music on the cardiac activity of a fetus in a cardiotocographic examination

Grażyna Gebuza1,A,C,D,E,F, Marta Zaleska2,B,C,E,F, Marzena Kaźmierczak2,C,E,F, Estera Mieczkowska2,C,E,F, Małgorzata Gierszewska2,C,E,F

1 Department of Obstetric Care Basics, Faculty of Health Sciences, Nicolaus Copernicus University in Toruń, Poland

2 Faculty of Health Sciences, Nicolaus Copernicus University in Toruń, Poland

Abstract

Background. Music therapy as an adjunct to treatment is rarely used in perinatology and obstetrics, despite the proven therapeutic effect. Auditory stimulation through music positively impacts the health of adults and infants, its special role being observed in the development of prematurely born neonates. It is equally interesting how music impacts fetuses.
Objectives. The aim of this study is to assess the parameters of fetuses through cardiotocographic recording in women in the 3rd trimester of pregnancy while listening to Pyotr Tchaikovsky’s “Sleeping Beauty” and “Swan Lake.”
Material and Methods. The study was conducted in 2015 at Dr. Jan Biziel 2nd University Hospital in Bydgoszcz, on 48 women in the 3rd trimester of pregnancy. The cardiotocographic parameters of the fetus were examined by means of a Sonicaid Team Standard Oxford apparatus (Huntleigh Healthcare, Cardiff, United Kingdom).
Results. Significant changes were observed in the number of uterine contractions, accelerations, episodes of higher variability, and fetal movements after listening to the music.
Conclusion. Listening to classical music can serve as a successful method of prophylaxis against premature deliveries, indicated by the lower number of uterine contractions, and in stimulating fetal movement in the case of a non-reactive non-stress test (NST). Music therapy, as a therapeutic method which is inexpensive and soothing, should be used more frequently in obstetrics wards, indicated by pathological pregnancies, isolation from the natural environment, and distress resulting from diagnostics and from being in an unfamiliar environment.

Key words

music therapy, uterine contractions, cardiotocography, short-term versatility, fetal movements

References (22)

  1. Rosendaal FR. Venous thrombosis: A multicausal disease. Lancet. 1999;353:1167–1173.
  2. Konstantinides SV, Torbicki A, Agnelli G, et al. Task force for the diagnosis and management of acute pulmonary embolism of the European Society of Cardiology (ESC). 2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J. 2014;43:3033–3069.
  3. Jenkins PV, Rawley O, Smith OP, O’Donnell JS. Elevated factor VIII levels and risk of venous thrombosis. Br J Haematol. 2012;157:653–663.
  4. de Groot PG, Derksen B, Lisman T, Meijers JC, Rosendaal FR. Lupus anticoagulants and the risk of a first episode of deep venous thrombosis. J Thromb Haemost. 2005;3:1993–1997.
  5. von Brühl ML, Stark K, Steinhart A, et al. Monocytes, neutrophils and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo. J Exp Med. 2012;209:819–835.
  6. Yamazaki M. Antiphospholipid antibody syndrome. In: Ichinose A, ed. Sciences of Thrombi, Hemostasis, and Angiology. Tokyo, Japan: Chugai-Igakusha, 2005:410–421.
  7. Kobayashi Y, Numano F. Angiitis. In: Morishita R, ed. Vascular Medicine. Tokyo, Japan: Medical Review; 2001:565–576.
  8. Agmon-Levin N, Damoiseaux J, Kallenberg C, et al. International recommendations for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies. Ann Rheum Dis. 2014;73:17–23.
  9. Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006;4:295–306.
  10. Pengo V, Tripodi A, Reber G, et al. Update of the guidelines for lupus anticoagulant detection. Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardization Committee of the International Society on Thrombosis and Hemostasis. J Thromb Haemost. 2009;7:1737–1740.
  11. Tripodi A, de Groot PE, Pengo V. Antiphospholipid syndrome: Laboratory detection, mechanisms of action and treatment. J Intern Med. 2011;270:110–122.
  12. Aviña-Zubieta JA, Vostretsova K, De Vera MA, Sayre EC, Choi HK. The risk of pulmonary embolism and deep venous thrombosis in systemic lupuserythematosus: A general population-based study. Semin Arthritis Rheum. 2015;45:195–201.
  13. Merkel PA, Lo GH, Holbrook JT, et al. High incidence of venous thrombotic events among patients with Wegener granulomatosis: The Wegener’s Clinical Occurrence of Thrombosis (WeCLOT) study. Ann Intern Med. 2005;142:620–626.
  14. Mustonen P, Lehtonen KV, Javela K, Puurunen M. Persistent antiphospholipid antibody (aPL) in asymptomatic carriers as a risk factor for future thrombotic events: A nationwide prospective study. Lupus. 2014;23:1468–1476.
  15. Pierangeli SS, Chen PP, Raschi E, et al. Antiphospholipid antibodies and the antiphospholipid syndrome: Pathogenic mechanisms. Semin Thromb Hemost. 2008;34:236–250.
  16. Roubey RA. Immunology of the antiphospholipid antibody syndrome. Arthritis Rheum. 1996;391:444–1454.
  17. Vlachoyiannopoulos PG, Routsias JG. A novel mechanism of thrombosis in antiphospholipid antibody syndrome. J Autoimmun. 2010;35:248–255.
  18. Roubey RA, Hoffman M. From antiphospholipid syndrome to antibody-mediated thrombosis. Lancet. 1997;350:1491–1493.
  19. Yalavarthi S, Gould TJ, Rao AN, et al. Release of neutrophil extracellular traps by neutrophils stimulated with antiphospholipid antibodies: A newly identified mechanism of thrombosis in the antiphospholipid syndrome. Arthritis Rheumatol. 2015;67:2990–3003.
  20. Ortel TL. Thrombosis and the antiphospholipid syndrome. Hematology Am Soc Hematol Educ Program. 2005;1:462–468.
  21. Basu A, Sanchez TW, Casiano CA. DFS70/LEDGFp75: An enigmatic autoantigen at the interface between autoimmunity, AIDS and cancer. Front Immunol. 2015;6:116. doi: 10.3389/fimmu.2015.00116.
  22. Marlet J, Ankri A, Charuel JL, et al. Thrombophilia Associated with Anti-DFS70 Autoantibodies. PLoS One. 2015;10(9):e0138671. doi: 10.1371/journal.pone.0138671.